Skip to main content
. 2024 Jan 11;12(1):158. doi: 10.3390/biomedicines12010158

Figure 6.

Figure 6

Influence of proton pump inhibitor therapy in smokers and non-smokers treated with vedolizumab: (a,b) clinical response at weeks 14 and 54; (c,d) clinical remission at weeks 14 and 5; (e,f) endoscopic remission at weeks 14 and 54; black bar: patients without PPI; grey bar: patients with PPI.